Cargando…
Aetiology of Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPNs) have estimated annual incidence rates for polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis of 0.84, 1.03, and 0.47 per 100,000. Prevalence is much higher, particularly for PV and ET, as mortality rates are relatively low. Patients...
Autores principales: | McMullin, Mary Frances, Anderson, Lesley Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408762/ https://www.ncbi.nlm.nih.gov/pubmed/32640679 http://dx.doi.org/10.3390/cancers12071810 |
Ejemplares similares
-
Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017) -
Molecular pathogenesis of the myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2021) -
Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023) -
Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms
por: Duncombe, Andrew S., et al.
Publicado: (2020) -
Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study
por: McMullin, Mary Frances, et al.
Publicado: (2016)